ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Mortality"

  • 2015 American Transplant Congress

    Muscle Mass Measurement Is Objective and More Predictive of Expected Mortality Than Functional Status in High MELD Liver Transplant Recipients

    J. Nolte,1 S. Gordon Burroughs,1 D. Victor,1 C. Mobley,1 N. Yu,2 T. Hirase,1 A. Saharia,1 A. Rajaraman,1 L. Moore,1 A. Gaber,1 R. Ghobrial.1

    1Surgery, Houston Methodist Hospital, Houston, TX; 2Radiology, Houston Methodist Hospital, Houston, TX.

    Introduction: Calculations used to determine expected survival post-liver transplant (OLT) are in part based on pre-OLT functional status. Functional status is subjectively measured by Karnofsky…
  • 2015 American Transplant Congress

    Kidney Transplant Outcomes in Marijuana Users

    P. Shrivastava,1 A. Naik,1 A. Sakhuja,1 Y. Lu,1 Y. Huang,1 F. Barrantes,2 F. Luan,3 S. Kulshrestha,4 M. Samaniego.1

    1Dept of Internal Medicine, University of Michigan, Ann Arbor, MI; 2Presbyterian Kidney Transplantation, Albuquerque, NM; 3Dept of Kidney and Pancreas Transplantation, St. Barnabas Medical Center, Livingston, NJ; 4Dept of Internal Medicine, University of Iowa, Iowa City, IA.

    Introduction: As Marijuana use is gaining social acceptance, many transplant centers face questions regarding candidacy of users for kidney transplantation. Currently its impact on post-transplantation…
  • 2015 American Transplant Congress

    Functional Status Predicts Mortality After Liver Transplant

    N. Dolgin,1,2 P. Martins,1 F. Anderson,1,2 A. Bozorgzadeh.1

    1Surgery, UMass Memorial Medical Center, Worcester, MA; 2Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA.

    Purpose: To investigate whether pre-transplant functional status predicts mortality after liver transplant (LT).Methods: We conducted a retrospective cohort study of first-time adult LT recipients using…
  • 2015 American Transplant Congress

    Sex Differences in Mortality Rate Among Patients Waiting for Liver Transplantation

    Z. Cui,1,2 X. Luo,2 A. Massie,2 D. Segev.2

    1Columbia University, New York; 2Johns Hopkins University, Baltimore.

    Livers are allocated according to MELD score without regard to patient demographics. However, MELD-adjusted risk of death may vary by sex, since serum creatinine level…
  • 2015 American Transplant Congress

    MELD Velocity – An Early Predictor of Increased Mortality Risk

    D. Ladner,1 K. Skibba,2 J. Kang,1 B. Ho,1 A. Kho,1 L. Kulik,1 A. Daud,1 M. Abecassis,1 A. Skaro.1

    1Northwestern University, Chicago, IL; 2Rosalind Franklin University of Medicine and Science, Chicago, IL.

    INTRODUCTION: MELD is a satisfactory predictor of 3-month mortality in patients with cirrhosis. However, sub-populations of patients at increased hazard of mortality, but not well…
  • 2015 American Transplant Congress

    Distal Splenorenal Shunt (DSRS): A Durable Bridge to Liver Transplantation

    J. Pomposelli, A. Tongyoo, R. Jenkins, M. Akoad, W. Lewis, E. Pomfret.

    Transplantation and Hepatobiliary Diseases, Lahey Clinic Medical Center, Burlington, MA.

    Background: Variceal bleeding has a high rate of in-hospital mortality approaching 50%. Patients with well-compensated cirrhosis and recurrent variceal bleeding may benefit from long-term prophylaxis…
  • 2015 American Transplant Congress

    Predictors of Time to Recurrence and Mortality Associated With Recurrent Hepatocellular Carcinoma After Liver Transplantation

    A. Bodzin, D. Reino, K. Lunsford, M. Harlander-Locke, D. Markovich, A. Zarrinpar, F. Kaldas, D. Farmer, R. Busuttil, V. Agopian.

    Transplantation, UCLA, Los Angeles, CA.

    Background: While recurrent hepatocellular carcinoma (HCC) after liver transplantation (LT) portends a poor prognosis, adjuvant therapy may prolong survival. We sought to identify factors that…
  • 2015 American Transplant Congress

    Serum Phosphorus Level Has Bidirectional Association With Graft Failure and Mortality in Kidney Transplant Recipients

    H. Jeon,1 J. An,2 K. Joo,1 C. Lim,2 Y. Oh,2 C. Ahn,1 S.-K. Park,3 Y. Kim,1 Y. Kim,4 J. Lee.2

    1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; 2Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea; 3Department of Internal Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; 4Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea.

    Hyperphosphatemia in kidney transplant recipients (KTRs) is known to predict a graft and patient survival in several studies. However, studies concerned with hypophosphatemia are scarce.…
  • 2015 American Transplant Congress

    Cardiac Troponin T (cTNT) in the Assessment of Kidney Transplant (KTx) Benefit and Risk

    F. Cosio,1 A. Grupper,1 P. Dean,2 H. Amer.1

    1Nephrology, Mayo Clinic, Rochester, MN; 2Surgery, Mayo Clinic, Rochester, MN.

    Introduction. Compared to waiting list (WL) KTx improves patient survival. However, mortality may increase early post-KTx. cTNT level at candidate evaluation is a strong, independent…
  • 2015 American Transplant Congress

    Associations Between Sirolimus Use and Outcomes After Liver Transplant for Hepatocellular Carcinoma

    E. Yanik,1 S. Chinnakotla,2 A. Israni,2,3 J. Snyder,2,3 S. Gustafson,3 E. Engels.1

    1Natl. Cancer Inst., Bethesda, MD; 2U. of Minnesota, Minneapolis, MN; 3Sci. Reg. of Transplant Recipients, Minneapolis, MN.

    A growing fraction of U.S. liver transplants are being done for the indication of hepatocellular carcinoma (HCC). HCC recurrence after transplant remains a major concern…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences